Circulatory arrest and renal function in open-heart surgery on infants.
This study was designed to evaluate the impact of circulatory arrest on renal function in open-heart surgery on infants. Renal function was described by diuresis, urine/plasma creatinine ratio, creatinine clearance, urinary albumin, and N-acetyl-beta-D-glucosaminidase measurements. Seven patients who underwent circulatory arrest (group 1) were compared with 37 patients operated on with cardiopulmonary bypass without circulatory arrest (group 2). In group 1, bypass time was 164 minutes and the lowest body temperature was 25.6 degrees C (median), compared with 106 minutes and 31.3 degrees C in group 2 (p < 0.05). Although diuresis and creatinine clearance revealed no differences between the groups, urine measurements, which had normal values before cardiopulmonary bypass, increased during reperfusion to 58.6 (range 16.2-75.5) mg gCrea(-1) albumin and to 14.8 (range 1.6-21.8) U gCrea(-1) N-acetyl-beta-D-glucosaminidase in group 1, compared with 8.1 (range 0-127.7) mg gCrea(-1) and 1.9 (range 0-47.8) U gCrea(-1) in group 2 (p < 0.05). Thus, deep hypothermic circulatory arrest (DHCA) subjected the kidney to ischemia reperfusion injury. Although the findings are mild and do not indicate severe ischemic renal damage, potential renal damage by DHCA should be taken into account when planning surgical procedures for congenital heart disease patients with additional risks of acute renal failure.
Dittrich
S
S
Deutsches Herzzentrum Berlin, Virchow Hospital, Humboldt University, Germany.
Priesemann
M
M
Fischer
T
T
Boettcher
W
W
Müller
C
C
Alexi-Meskishvili
V
V
Lange
P E
PE
D058186:Acute Kidney Injury / Q000097:blood / Q000209:etiology* / Q000652:urine; D002315:Cardiopulmonary Bypass; D003404:Creatinine / Q000097:blood; D006324:Heart Arrest, Induced / Q000009:adverse effects*; D006330:Heart Defects, Congenital / Q000601:surgery*; D006801:Humans; D007223:Infant; D007430:Intraoperative Care; D011182:Postoperative Care; D011507:Proteinuria / Q000652:urine; D016896:Treatment Outcome
D003404:Creatinine